Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,252.20
Bid: 1,253.20
Ask: 1,253.60
Change: 0.00 (0.00%)
Spread: 0.40 (0.03%)
Open: 1,248.00
High: 1,255.60
Low: 1,221.60
Yest. Close: 1,243.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

INSIGHT-Extreme medicine: The search for new antibiotics

* World crying out for new antibiotics as superbugs evolve * Scientists seek new chemistry in hard-to-reach places * "Back to nature" search aided by genome mining technology By Kate Kelland and Ben Hirschler NORWICH, England, Aug 17 (Reuters) - Pampering leafcutter ants w

17 Aug 14 08:00

Investigators linked with GSK will not appeal sentence

A British corporate investigator and his wife, detained for the work they did for pharmaceuticals giant GSK, will not appeal a Chinese court's decision to sentence them to prison, Reuters reported on Friday. Peter Humphrey and his American wife Yu Yingzeng were sentenced to two and a half and two y

15 Aug 14 12:37

PRESS: Glaxo Linked Investigators Will Not Appeal Sentence - Reuters

15 Aug 14 10:40

GSK-linked investigators will not appeal China sentence-lawyer

SHANGHAI, Aug 15 (Reuters) - British corporate investigator Peter Humphrey and his American wife Yu Yingzeng do not plan to appeal a Chinese court's decision to sentence them to prison, a lawyer told Reuters on Friday. "All us lawyers have met with the couple and they said they don't want t

15 Aug 14 06:14

UK MIDDAY BRIEFING: Carillion In Talks With Balfour Beatty Shareholders

14 Aug 14 11:11

TOP NEWS: Carillion Appeals To Balfour Beatty Shareholders

14 Aug 14 10:19

UK MORNING BRIEFING: Carillion Woos Balfour Beatty Shareholders

14 Aug 14 07:23

PRESS: European Drug Firms Interested In InterMune - Bloomberg

14 Aug 14 05:58

UPDATE 2-InterMune taps banks as it braces for buyout bids -sources

(Adds share price, healthcare M&A activity) By Soyoung Kim and Olivia Oran NEW YORK, Aug 13 (Reuters) - Biotechnology company InterMune Inc is working with financial advisers to evaluate strategic options as it braces for potential takeover interest from larger drugmakers, people fami

13 Aug 14 17:49

UPDATE 1-InterMune taps banks as it braces for buyout bids -sources

(Adds details about company) By Soyoung Kim and Olivia Oran NEW YORK, Aug 13 (Reuters) - Biotechnology company InterMune Inc is working with financial advisers to evaluate strategic options as it braces for potential takeover interest from larger drugmakers, people familiar with the m

13 Aug 14 17:32

WRAPUP 3-WHO backs use of experimental Ebola drugs in West Africa

* Liberia to treat infected doctors with trial drug ZMapp * Spanish priest who received ZMapp dies in Madrid * No licensed treatments or vaccines for Ebola * Ghana delays academic year for tertiary institutions (Adds Canada to donate Ebola vaccine) By Kate Kelland and St

12 Aug 14 22:41

WRAPUP 2-WHO backs use of experimental Ebola drugs in West African epidemic

* Liberia to treat infected doctors with trial drug ZMapp * Spanish priest who received ZMapp dies in Madrid * No licensed treatments or vaccines for Ebola * Ghana delays academic year for tertiary institutions (Updates with quotes, detail) By Kate Kelland and Stephanie

12 Aug 14 21:18

WHO hopes for more Ebola drug doses, vaccine progress by end of year

* Supply challenge after green light to use unproven drugs * Race to scale up production, testing of Ebola treatments * Two vaccines set to enter clinical trials in coming weeks By Ben Hirschler LONDON, Aug 12 (Reuters) - World Health Organization experts fighting the worl

12 Aug 14 16:46

DIRECTOR DEALINGS: GlaxoSmithKline Directors Buy Shares

12 Aug 14 16:27

WRAPUP 1-WHO backs use of experimental Ebola drugs in West Africa epidemic

* Liberia to treat infected doctors with trial drug ZMapp * Spanish priest who received ZMapp dies in Madrid * No licensed treatments or vaccines for Ebola * Virus has killed more than 1,000 people in West Africa By Kate Kelland and Stephanie Nebehay LONDON/GENEVA, A

12 Aug 14 16:25

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.